Clinical Trial Update: Pembrolizumab and Radiation Therapy in Treating Patients With Intermediate or High-Grade Soft Tissue Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for pembrolizumab with radiation therapy in intermediate- or high-grade soft tissue sarcoma (Phase 1/2). The study has completed and resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Soft Tissue Sarcoma, Recurrent Soft Tissue Sarcoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-07-23